Google
GELS — GELTEQ LIMITED ORDINARY SHARES (Healthcare >> Drug Manufacturers - Specialty & Generic)
GELS FAQ
What is GELS's ROE?
GELTEQ LIMITED ORDINARY SHARES reports a Return on Equity (ROE) of -42.05%.
What is GELS's dividend yield?
GELTEQ LIMITED ORDINARY SHARES offers a dividend yield of 0.00%.
What is GELS's Deepscope Quality Score?
Deepscope rates GELS's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GELS?
Deepscope's AI Timing Score for GELS is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GELS belong to?
GELTEQ LIMITED ORDINARY SHARES is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 0.50
Price
-0.02
(-3.31%)
Day Change
|
|
|---|
GELS, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.50 |
| PBV / Sector |
0.32 / 2.76
GREAT
|
| Earning Per Share | -0.66 |
| PE / Sector |
N/A / 23.64
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
0.08 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:25 |
| Symbol | GELS |
| Name | GELTEQ LIMITED ORDINARY SHARES |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 10.71 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4.98 / 9,835.56 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Monash Innovation Labs, Clayton, VIC, Australia, 3800
Phone: 61 3 9087 3990
Website: https://www.gelteq.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
